Opdivo
Stock Recap #PipelineProspector

Pipeline Prospector 2024 highlights: Rise in new breed of biotechs with maiden approvals; GLP-1 meds show promise beyond obesity

December proved to be one of the most bearish months of 2024 for the biopharma sector. The Nasdaq Bi